Cochrane · systematic review · CD009191

Angiotensin‐converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease

Sasongko, TH, Nagalla, S · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Cystic Fibrosis and Genetic Disorders2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 6 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

ACE inhibitors compared with placebo for proteinuria and microalbuminuria in people with sickle cell disease

Population: adults and children with proteinuria or microalbuminuria due to sickle cell disease
6 questions
OutcomeEffectEvidenceStatus / GRADE
Urinary protein or albumin excretion ‐ total albumin excretion at 6 months
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Serum creatinine
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Electrolyte levels
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Mean blood pressure (mmHg)
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Hemoglobin concentration (g/dL)
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Any reported adverse effect or toxicity
ACE inhibitors vs placebo
no estimate extracted1 study · 22 participantsVery low
Downgraded: risk of bias, imprecision, indirectness